Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ullrich

Showing results (71-80 of 198) with videos related to

Pageof 20
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Nature Communications|December 8, 2025
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancerLydia Meder, Charlotte I Orschel, Cyrielle L Bouchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin LymphomaJan-Michel Heger, Laman Mammadova, Julia Mattlener, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Blood|June 15, 2022
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignanciesD Thomalla, L Beckmann, C Grimm, et al.
Genome Biology|February 5, 2015
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing dataLynnette Fernandez-Cuesta, Ruping Sun, Roopika Menon, et al.
Nature Communications|September 18, 2021
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-IJohannes Brägelmann, Carina Lorenz, Sven Borchmann, et al.
Cancer Discovery|January 29, 2014
CD74-NRG1 fusions in lung adenocarcinomaLynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, et al.
Pageof 20

Showing results (71-80 of 198) with videos related to

Sort By:
Pageof 20
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancerMartin L Sos, Felix Dietlein, Martin Peifer, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Nature Communications|December 8, 2025
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancerLydia Meder, Charlotte I Orschel, Cyrielle L Bouchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin LymphomaJan-Michel Heger, Laman Mammadova, Julia Mattlener, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
The Journal of Clinical Investigation|August 22, 2023
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancerFlorian Malchers, Lucia Nogova, Martijn Ha van Attekum, et al.
Blood|June 15, 2022
Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignanciesD Thomalla, L Beckmann, C Grimm, et al.
Genome Biology|February 5, 2015
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing dataLynnette Fernandez-Cuesta, Ruping Sun, Roopika Menon, et al.
Nature Communications|September 18, 2021
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-IJohannes Brägelmann, Carina Lorenz, Sven Borchmann, et al.
Cancer Discovery|January 29, 2014
CD74-NRG1 fusions in lung adenocarcinomaLynnette Fernandez-Cuesta, Dennis Plenker, Hirotaka Osada, et al.
Pageof 20